Monoclonal antibodies can hold the coronavirus in check by mimicking the body’s natural immune defenses. The drugs, produced by Regeneron and Eli Lilly, can... Antibody drugs for COVID are cumbersome tool against surges

Monoclonal antibodies can hold the coronavirus in check by mimicking the body’s natural immune defenses. The drugs, produced by Regeneron and Eli Lilly, can keep people with mild to moderate COVID-19 out of the hospital and have emergency authorization for people over 65, as well as others with certain underlying health conditions. On Wednesday, Michigan Gov. Gretchen Whitmer urged people in her state who qualify for these drugs to seek them out, recalling that President Trump took the treatment after he fell ill with COVID-19.


Sign up for our free email alerts and follow us on Facebook and on Twitter @gahealthnews.
Help us fulfill our nonprofit mission with a tax-deductible donation!

NPR

No comments so far.

Be first to leave comment below.

Your email address will not be published. Required fields are marked *

Please leave these two fields as-is:

Help us pursue our nonprofit mission with a tax-deductible donation.

Credit Cards

EVERY LITTLE BIT HELPS
Donations Welcome

Donate Icon